カテゴリー： QYResearch, 世界

免疫の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書（QY21APR3057）
◆英語タイトル：Global Immunology Market Size, Status and Forecast 2021-2027
◆商品コード：QY21APR3057
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2021年4月
◆ページ数：95
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥499,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥748,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
本調査資料では、免疫の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫ブースター、免疫抑制剤）、用途別市場規模（自己免疫疾患、腫瘍、臓器移植、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・免疫の市場動向
・企業の競争状況、市場シェア
・免疫の種類別市場規模（免疫ブースター、免疫抑制剤）
・免疫の用途別市場規模（自己免疫疾患、腫瘍、臓器移植、その他）
・免疫の北米市場規模2016-2027（アメリカ、カナダ）
・免疫の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・免疫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・免疫の中南米市場規模2016-2027（メキシコ、ブラジル）
・免疫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Amgen、F. Hoffmann-La Roche、Johnson & Johnson、Bionor Pharma、Celgene、Cellectar Biosciences、eFFECTOR Therapeutics）
・結論
【レポートの概要】

The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body’s healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body’s defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body’s cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.
One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body’s immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.

Market Analysis and Insights: Global Immunology Market
The global Immunology market size is projected to reach US$ 96520 million by 2026, from US$ 61890 million in 2019, at a CAGR of 6.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunology market.

Global Immunology Scope and Market Size
Immunology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immuno Boosters
Immunosuppressants

Segment by Application
Autoimmune Diseases
Oncology
Organ Transplantation
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Bionor Pharma
Celgene
Cellectar Biosciences
eFFECTOR Therapeutics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immuno Boosters
1.2.3 Immunosuppressants
1.3 Market by Application
1.3.1 Global Immunology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Organ Transplantation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immunology Market Perspective (2016-2027)
2.2 Immunology Growth Trends by Regions
2.2.1 Immunology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunology Historic Market Share by Regions (2016-2021)
2.2.3 Immunology Forecasted Market Size by Regions (2022-2027)
2.3 Immunology Industry Dynamic
2.3.1 Immunology Market Trends
2.3.2 Immunology Market Drivers
2.3.3 Immunology Market Challenges
2.3.4 Immunology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immunology Players by Revenue
3.1.1 Global Top Immunology Players by Revenue (2016-2021)
3.1.2 Global Immunology Revenue Market Share by Players (2016-2021)
3.2 Global Immunology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunology Revenue
3.4 Global Immunology Market Concentration Ratio
3.4.1 Global Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunology Revenue in 2020
3.5 Immunology Key Players Head office and Area Served
3.6 Key Players Immunology Product Solution and Service
3.7 Date of Enter into Immunology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immunology Breakdown Data by Type
4.1 Global Immunology Historic Market Size by Type (2016-2021)
4.2 Global Immunology Forecasted Market Size by Type (2022-2027)

5 Immunology Breakdown Data by Application
5.1 Global Immunology Historic Market Size by Application (2016-2021)
5.2 Global Immunology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immunology Market Size (2016-2027)
6.2 North America Immunology Market Size by Type
6.2.1 North America Immunology Market Size by Type (2016-2021)
6.2.2 North America Immunology Market Size by Type (2022-2027)
6.2.3 North America Immunology Market Size by Type (2016-2027)
6.3 North America Immunology Market Size by Application
6.3.1 North America Immunology Market Size by Application (2016-2021)
6.3.2 North America Immunology Market Size by Application (2022-2027)
6.3.3 North America Immunology Market Size by Application (2016-2027)
6.4 North America Immunology Market Size by Country
6.4.1 North America Immunology Market Size by Country (2016-2021)
6.4.2 North America Immunology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Immunology Market Size (2016-2027)
7.2 Europe Immunology Market Size by Type
7.2.1 Europe Immunology Market Size by Type (2016-2021)
7.2.2 Europe Immunology Market Size by Type (2022-2027)
7.2.3 Europe Immunology Market Size by Type (2016-2027)
7.3 Europe Immunology Market Size by Application
7.3.1 Europe Immunology Market Size by Application (2016-2021)
7.3.2 Europe Immunology Market Size by Application (2022-2027)
7.3.3 Europe Immunology Market Size by Application (2016-2027)
7.4 Europe Immunology Market Size by Country
7.4.1 Europe Immunology Market Size by Country (2016-2021)
7.4.2 Europe Immunology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immunology Market Size (2016-2027)
8.2 Asia-Pacific Immunology Market Size by Type
8.2.1 Asia-Pacific Immunology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunology Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunology Market Size by Application
8.3.1 Asia-Pacific Immunology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunology Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunology Market Size by Region
8.4.1 Asia-Pacific Immunology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immunology Market Size (2016-2027)
9.2 Latin America Immunology Market Size by Type
9.2.1 Latin America Immunology Market Size by Type (2016-2021)
9.2.2 Latin America Immunology Market Size by Type (2022-2027)
9.2.3 Latin America Immunology Market Size by Type (2016-2027)
9.3 Latin America Immunology Market Size by Application
9.3.1 Latin America Immunology Market Size by Application (2016-2021)
9.3.2 Latin America Immunology Market Size by Application (2022-2027)
9.3.3 Latin America Immunology Market Size by Application (2016-2027)
9.4 Latin America Immunology Market Size by Country
9.4.1 Latin America Immunology Market Size by Country (2016-2021)
9.4.2 Latin America Immunology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immunology Market Size (2016-2027)
10.2 Middle East & Africa Immunology Market Size by Type
10.2.1 Middle East & Africa Immunology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunology Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunology Market Size by Application
10.3.1 Middle East & Africa Immunology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunology Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunology Market Size by Country
10.4.1 Middle East & Africa Immunology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Immunology Introduction
11.1.4 AbbVie Revenue in Immunology Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Immunology Introduction
11.2.4 Amgen Revenue in Immunology Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Immunology Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Immunology Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunology Introduction
11.4.4 Johnson & Johnson Revenue in Immunology Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Bionor Pharma
11.5.1 Bionor Pharma Company Details
11.5.2 Bionor Pharma Business Overview
11.5.3 Bionor Pharma Immunology Introduction
11.5.4 Bionor Pharma Revenue in Immunology Business (2016-2021)
11.5.5 Bionor Pharma Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Immunology Introduction
11.6.4 Celgene Revenue in Immunology Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Cellectar Biosciences
11.7.1 Cellectar Biosciences Company Details
11.7.2 Cellectar Biosciences Business Overview
11.7.3 Cellectar Biosciences Immunology Introduction
11.7.4 Cellectar Biosciences Revenue in Immunology Business (2016-2021)
11.7.5 Cellectar Biosciences Recent Development
11.8 eFFECTOR Therapeutics
11.8.1 eFFECTOR Therapeutics Company Details
11.8.2 eFFECTOR Therapeutics Business Overview
11.8.3 eFFECTOR Therapeutics Immunology Introduction
11.8.4 eFFECTOR Therapeutics Revenue in Immunology Business (2016-2021)
11.8.5 eFFECTOR Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 免疫の世界市場規模・現状・予測2021年-2027年(Global Immunology Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 計算免疫学の世界市場規模・現状・予測2021年-2027年 Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations. Market Analysis and Insights: Global Computational Immunology Market The global Computational Immunology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities...
  • 後天性血友病A治療の世界市場規模・現状・予測2021年-2027年 ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acquired hemophilia A Treatment market to help players in achieving a strong market position....
  • 計算免疫学の世界市場規模・現状・予測2021年-2027年 Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations. Market Analysis and Insights: Global Computational Immunology Market The global Computational Immunology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities...
  • 免疫の世界市場規模・現状・予測2021年-2027年 The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's...
  • エキソストシン1/2ヘテロダイマーの世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Exostosin 1/2 Heterodimer Market The global Exostosin 1/2 Heterodimer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exostosin 1/2 Heterodimer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exostosin 1/2 Heterodimer market in terms...
  • 組換え治療用抗体＆タンパク質の世界市場規模・現状・予測2021年-2027年 Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein. Recombinant proteins have gained significant traction for therapeutic applications and the number of proteins either launched or approved into clinical trials has continually increased over the past two decades. According to the National Center for Biotechnology Information (NCBI) data of 2017, the U.S. Food and Drug Administration (FDA) approved...
  • In Situハイブリダイゼーションの世界市場規模・現状・予測2021年-2027年 In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections. North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies,...
  • 血液ウイルス検査の世界市場規模・現状・予測2021年-2027年 Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells they infect, or cause inflammation that can damage the complete organ. A viral infection can occur in different parts of the body such as intestine, respiratory tract and lungs. Common viral infections include common cold which is caused due to infection in the upper respiratory tract and influenza. Diagnostic virology is formulating...
  • 細胞分離の世界市場規模・現状・予測2021年-2027年 Cell separation has gained importance in the fields of medicine and biology as it is an essential component of cellular therapy and disease diagnosis. The recent expansion of the field of cell separation is linked to an increase the mortality rate due to chronic diseases as majority of these diseases can be treated using cell-based therapies. Cell separation technologies involve the separation of cells from a heterogeneous cell mixture according to their intracellular or extracellular properties. Market Analysis and Insights: Global Cell Separation Market The global Cell Separation market size is projected to reach US$ XX million by 2026, from...
  • RNAベース治療薬＆ワクチンの世界市場規模・現状・予測2021年-2027年 RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions. RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases. Market Analysis and Insights: Global RNA-Based Therapeutics and Vaccines Market The global RNA-Based Therapeutics and Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy...
  • 特殊検査の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Esoteric Testing Market The global Esoteric Testing market size is projected to reach US$ 37280 million by 2026, from US$ 18740 million in 2019, at a CAGR of 10.2% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Esoteric Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Esoteric Testing market in terms of revenue. On the...
  • デジタルPCR-dPCRの世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Digital PCR-dPCR Market The global Digital PCR-dPCR market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital PCR-dPCR market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital PCR-dPCR market in terms of revenue. On the...
  • ナノテクノロジードラッグデリバリーの世界市場規模・現状・予測2021年-2027年 Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions. Nanotechnology drug delivery is a growing field and is witnessing increasing acceptance in health care applications. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others....
  • In-Situハイブリダイゼーションの世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global In-Situ Hybridization Market The global In-Situ Hybridization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-Situ Hybridization market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-Situ Hybridization market in terms of revenue. On the...
  • クロファラビンの世界市場規模・現状・予測2021年-2027年 Clofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. Market Analysis and Insights: Global Clofarabine Market The global Clofarabine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clofarabine market to help players in achieving a strong market position. Buyers of the report can...